Inovio As

USPTO Granted Patents = 4

CIPO Patents = 2

Forward Citations = 141

Loading Chart...

7 inventors (with patents filed for the assignee):

Iacob Mathiesen (4 out of 14 patents)

Torunn E Tjelle (2 out of 5 patents)

Knut Arvid Sorensen Rekdahl (1 out of 2 patents)

4. Bjorn David-Andersen (1 out of 2 patents)

5. Terje Lomo (1 out of 3 patents)

6. Knut Arvid Sørensen Rekdahl (1 out of 1 patent)

7. Bjøm David-Andersen (1 out of 1 patent)

8. Knut Arvid Rekdahl (0 patent)

9. Torunn Elisabeth Tjelle (0 patent)

4 patents: Sort by Forward Citations

1. 10376692 - Electroporation device and injection apparatus (2019-08-13),

2. 7931640 - Method for muscle delivery of drugs, nucleic acids and other compounds (2011-04-26),

3. 7328064 - Electroporation device and injection apparatus (2008-02-05),

4. 6610044 - Method for genetic immunization (2003-08-26),

Inovio is a biotechnology company focused on developing DNA-based immunotherapies and vaccines to prevent and treat infectious diseases and cancers. Their proprietary platform enables the delivery of DNA directly into cells, stimulating a targeted immune response. Inovio is dedicated to advancing innovative treatments with the potential to transform the way diseases are prevented and treated.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#30 in

#392 in Norway

NO